Literature DB >> 19541688

Somatosensory temporal discrimination in patients with primary focal dystonia.

A Scontrini1, A Conte, G Defazio, M Fiorio, G Fabbrini, A Suppa, M Tinazzi, A Berardelli.   

Abstract

PURPOSES: To determine whether somatosensory temporal discrimination will reliably detect subclinical sensory impairment in patients with various forms of primary focal dystonia.
METHODS: The somatosensory temporal discrimination threshold (STDT) was tested in 82 outpatients affected by cranial, cervical, laryngeal and hand dystonia. Results were compared with those for 61 healthy subjects and 26 patients with hemifacial spasm, a non-dystonic disorder. STDT was tested by delivering paired stimuli starting with an interstimulus interval of 0 ms followed by a progressively increasing interstimulus interval.
RESULTS: STDT was abnormal in all the different forms of primary focal dystonias in all three body regions (eye, hand and neck), regardless of the distribution and severity of motor symptoms. Receiver operating characteristic curve analysis calculated in the three body regions yielded high diagnostic sensitivity and specificity for STDT abnormalities.
CONCLUSIONS: These results provide definitive evidence that STDT abnormalities are a generalised feature of patients with primary focal dystonias and are a valid tool for screening subclinical sensory abnormalities.

Entities:  

Mesh:

Year:  2009        PMID: 19541688     DOI: 10.1136/jnnp.2009.178236

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  47 in total

Review 1.  Neurophysiology of dystonia: The role of inhibition.

Authors:  Mark Hallett
Journal:  Neurobiol Dis       Date:  2010-09-15       Impact factor: 5.996

2.  INCREASED BLINKING MAY BE A PRECURSOR OF BLEPHAROSPASM: A LONGITUDINAL STUDY.

Authors:  Antonella Conte; Gina Ferrazzano; Giovanni Defazio; Giovanni Fabbrini; Mark Hallett; Alfredo Berardelli
Journal:  Mov Disord Clin Pract       Date:  2017-06-02

3.  Temporal discrimination thresholds in adult-onset primary torsion dystonia: an analysis by task type and by dystonia phenotype.

Authors:  D Bradley; R Whelan; O Kimmich; S O'Riordan; N Mulrooney; P Brady; R Walsh; R B Reilly; S Hutchinson; F Molloy; M Hutchinson
Journal:  J Neurol       Date:  2011-06-08       Impact factor: 4.849

Review 4.  Botulinum toxin in the management of blepharospasm: current evidence and recent developments.

Authors:  Amy Hellman; Diego Torres-Russotto
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

5.  Differences in active range of motion measurements in the upper extremity of patients with writer's cramp compared with healthy controls.

Authors:  Prachaya Srivanitchapoom; Ejaz A Shamim; Pierre Diomi; Takaaki Hattori; Sanjay Pandey; Sherry Vorbach; Jung E Park; Tianxia Wu; Sungyoung Auh; Mark Hallett
Journal:  J Hand Ther       Date:  2016-02-18       Impact factor: 1.950

6.  The somatosensory temporal discrimination threshold changes after a placebo procedure.

Authors:  Mirta Fiorio; Mehran Emadi Andani; Serena Recchia; Michele Tinazzi
Journal:  Exp Brain Res       Date:  2018-08-14       Impact factor: 1.972

Review 7.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

Review 8.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

9.  Temporal discrimination threshold with healthy aging.

Authors:  Vesper Fe Marie Llaneza Ramos; Alina Esquenazi; Monica Anne Faye Villegas; Tianxia Wu; Mark Hallett
Journal:  Neurobiol Aging       Date:  2016-04-21       Impact factor: 4.673

Review 10.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.